NHS cancer gene database to identify patients at risk
NHS England is creating a national register of 120 cancer-linked genes to identify inherited risk and enable targeted screening, monitoring, and personalized treatment.
Two new subtypes of MS found in exciting' breakthrough
Artificial intelligence identified two biological MS subtypes—early sNfL and late sNfL—enabling targeted risk stratification and the potential for personalised treatments using blood tests and MRI.